Publication | Open Access
Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study)
67
Citations
10
References
2015
Year
Apixaban was well-tolerated and had a favorable safety profile. No clinically important efficacy difference compared with UFH/warfarin was observed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1